Drug effects on pre- and postsynaptic dopamine receptors
Andén, N.E.; Grabowska-Andén, M.
Advances in Biochemical Psychopharmacology 24: 57-64
1980
ISSN/ISBN: 0065-2229 PMID: 6105802 Document Number: 162584
Document emailed within 1 workday
Related Documents
Wang, X.L.; Jin, G.Z.; Yu, L.P.; Li, J.H. 1982: Effect of tetrahydroberberine on blockade of pre- and postsynaptic dopamine receptors Zhongguo Yao Li Xue Bao 3(2): 73-77Berga, P.; Beckett, P.R.; Roberts, D.J. 1979: Antagonism of pre- and postsynaptic dopamine receptors by clebopride and related orthopramides Archivos de Farmacologia y Toxicologia 5(3): 144-146
Fuller, R.W.; Clemens, J.A.; Hynes, M.D. 1982: Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia Journal of Clinical Psychopharmacology 2(6): 371-375
Katzman, R.; Makman, M.H.; Ahn, H.S.; Mishra, R.K.; Gardner, E. 1977: Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors Transactions of the American Neurological Association 102: 76-79
Kikuchi, T.; Tottori, K.; Uwahodo, Y.; Hirose, T.; Miwa, T.; Oshiro, Y.; Morita, S. 1995: 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity Journal of Pharmacology and Experimental Therapeutics 274(1): 329-336
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Miura, J. 2002: Effects of antidepressants on the expression of rat brain dopamine receptors Hokkaido Journal of Medical Science 77(5): 407-417
Jeste, D.V.; Wyatt, R.J. 1981: Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? Journal of Clinical Psychiatry 42(12): 455-457
Acton, G. 1988: Effects of D-5-hydroxytryptophan and D-DOPA on binding at serotonin and dopamine receptors Research Communications in Chemical Pathology and Pharmacology 60(1): 129-132
Gnegy, M.; Uzunov, P.; Costa, E. 1977: Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors Journal of Pharmacology and Experimental Therapeutics 202(3): 558-564
Abaimov, D.A.; Zimin, I.A.; Kovalev, G.I. 2008: Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo Eksperimental'naia i Klinicheskaia Farmakologiia 71(1): 18-21
Kenny, A.M.; Schneider, M.B.; Baden, D.R.; Pfeiffer, R.F.; Murrin, L.C. 1986: Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats Neurology 36(3): 400-404
Schuurkes, J.A.; Van Nueten, J.M. 1981: Effects of dopamine and its antagonist domperidone cannot be explained by an effect on alpha 1-adrenergic receptors Archives Internationales de Pharmacodynamie et de Therapie 250(2): 324-327
Criswell, H.; Mueller, R.A.; Breese, G.R. 1988: Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine Journal of Pharmacology and Experimental Therapeutics 244(2): 493-500
Dwoskin, L.P.; Zahniser, N.R. 1986: Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors Journal of Pharmacology and Experimental Therapeutics 239(2): 442-453
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374
Novoselov, I.A.; Raevskiĭ, K.S. 2003: Effects of antagonists of the various subtypes of dopamine receptors on the locomotor activity of C57BL mice induced by psychostimulators Eksperimental'naia i Klinicheskaia Farmakologiia 66(6): 3-5
Georgiev, V.; Petkova, B.; Kambourova, T. 1988: Adaptive changes in the effects of angiotensin Ii on the convulsive-seizure threshold in cases of altered sensitivity of dopamine receptors Methods and Findings in Experimental and Clinical Pharmacology 10(5): 295-299
Cuenca, E. 1981: Role of postsynaptic noradrenergic receptors in the mechanism of action of antidepressants L'Encephale 7(4 Suppl): 397